222 related articles for article (PubMed ID: 25093290)
21. Expression of the Ets transcription factor EHF in serous ovarian carcinoma effusions is a marker of poor survival.
Brenne K; Nymoen DA; Hetland TE; Trope' CG; Davidson B
Hum Pathol; 2012 Apr; 43(4):496-505. PubMed ID: 21855111
[TBL] [Abstract][Full Text] [Related]
22. HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma.
Davidson B; Elstrand MB; McMaster MT; Berner A; Kurman RJ; Risberg B; Trope CG; Shih IeM
Gynecol Oncol; 2005 Jan; 96(1):42-7. PubMed ID: 15589578
[TBL] [Abstract][Full Text] [Related]
23. Granulin-epithelin precursor is a novel prognostic marker in epithelial ovarian carcinoma.
Davidson B; Alejandro E; Flørenes VA; Goderstad JM; Risberg B; Kristensen GB; Trope CG; Kohn EC
Cancer; 2004 May; 100(10):2139-47. PubMed ID: 15139056
[TBL] [Abstract][Full Text] [Related]
24. Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma.
Kleinberg L; Dong HP; Holth A; Risberg B; Trope' CG; Nesland JM; Flørenes VA; Davidson B
Hum Pathol; 2009 Jun; 40(6):795-806. PubMed ID: 19157506
[TBL] [Abstract][Full Text] [Related]
25. The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions.
Davidson B; Holth A; Hellesylt E; Tan TZ; Huang RY; Tropé C; Nesland JM; Thiery JP
Hum Pathol; 2015 Jan; 46(1):1-8. PubMed ID: 25455994
[TBL] [Abstract][Full Text] [Related]
26. Calreticulin expression is reduced in high-grade ovarian serous carcinoma effusions compared with primary tumors and solid metastases.
Vaksman O; Davidson B; Tropé C; Reich R
Hum Pathol; 2013 Dec; 44(12):2677-83. PubMed ID: 24060004
[TBL] [Abstract][Full Text] [Related]
27. Heparanase expression correlates with poor survival in metastatic ovarian carcinoma.
Davidson B; Shafat I; Risberg B; Ilan N; Trope' CG; Vlodavsky I; Reich R
Gynecol Oncol; 2007 Feb; 104(2):311-9. PubMed ID: 17030350
[TBL] [Abstract][Full Text] [Related]
28. The PAC-1 dual specificity phosphatase predicts poor outcome in serous ovarian carcinoma.
Givant-Horwitz V; Davidson B; Goderstad JM; Nesland JM; Tropé CG; Reich R
Gynecol Oncol; 2004 May; 93(2):517-23. PubMed ID: 15099972
[TBL] [Abstract][Full Text] [Related]
29. Netrin-4 is upregulated in breast carcinoma effusions compared to corresponding solid tumors.
Yuan Y; Leszczynska M; Konstantinovsky S; Tropé CG; Reich R; Davidson B
Diagn Cytopathol; 2011 Aug; 39(8):562-6. PubMed ID: 20730893
[TBL] [Abstract][Full Text] [Related]
30. Kallikrein 4 expression is up-regulated in epithelial ovarian carcinoma cells in effusions.
Davidson B; Xi Z; Klokk TI; Tropé CG; Dørum A; Scheistrøen M; Saatcioglu F
Am J Clin Pathol; 2005 Mar; 123(3):360-8. PubMed ID: 15716231
[TBL] [Abstract][Full Text] [Related]
31. Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions.
Davidson B; Berner A; Nesland JM; Risberg B; Kristensen GB; Tropé CG; Bryne M
Hum Pathol; 2000 Sep; 31(9):1081-7. PubMed ID: 11014575
[TBL] [Abstract][Full Text] [Related]
32. APOA1 mRNA expression in ovarian serous carcinoma effusions is a marker of longer survival.
Tuft Stavnes H; Nymoen DA; Hetland Falkenthal TE; Kærn J; Tropé CG; Davidson B
Am J Clin Pathol; 2014 Jul; 142(1):51-7. PubMed ID: 24926085
[TBL] [Abstract][Full Text] [Related]
33. New determinates of disease progression and outcome in metastatic ovarian carcinoma.
Davidson B; Reich R; Trope CG; Wang TL; Shih IeM
Histol Histopathol; 2010 Dec; 25(12):1591-609. PubMed ID: 20886439
[TBL] [Abstract][Full Text] [Related]
34. Proteomic analysis of malignant ovarian cancer effusions as a tool for biologic and prognostic profiling.
Davidson B; Espina V; Steinberg SM; Flørenes VA; Liotta LA; Kristensen GB; Tropé CG; Berner A; Kohn EC
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):791-9. PubMed ID: 16467090
[TBL] [Abstract][Full Text] [Related]
35. Expression and clinical role of growth differentiation factor-15 in ovarian carcinoma effusions.
Bock AJ; Stavnes HT; Kempf T; Tropè CG; Berner A; Davidson B; Staff AC
Int J Gynecol Cancer; 2010 Dec; 20(9):1448-55. PubMed ID: 21336029
[TBL] [Abstract][Full Text] [Related]
36. Ets-1 mRNA expression in effusions of serous ovarian carcinoma patients is a marker of poor outcome.
Davidson B; Risberg B; Goldberg I; Nesland JM; Berner A; Tropé CG; Kristensen GB; Bryne M; Reich R
Am J Surg Pathol; 2001 Dec; 25(12):1493-500. PubMed ID: 11717538
[TBL] [Abstract][Full Text] [Related]
37. E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions.
Davidson B; Berner A; Nesland JM; Risberg B; Berner HS; Tropè CG; Kristensen GB; Bryne M; Ann Florenes V
J Pathol; 2000 Dec; 192(4):460-9. PubMed ID: 11113863
[TBL] [Abstract][Full Text] [Related]
38. Exosome-derived miRNAs and ovarian carcinoma progression.
Vaksman O; Tropé C; Davidson B; Reich R
Carcinogenesis; 2014 Sep; 35(9):2113-20. PubMed ID: 24925027
[TBL] [Abstract][Full Text] [Related]
39. NK- and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma.
Dong HP; Elstrand MB; Holth A; Silins I; Berner A; Trope CG; Davidson B; Risberg B
Am J Clin Pathol; 2006 Mar; 125(3):451-8. PubMed ID: 16613351
[TBL] [Abstract][Full Text] [Related]
40. HMGA2 protein expression in ovarian serous carcinoma effusions, primary tumors, and solid metastases.
Hetland TE; Holth A; Kærn J; Flørenes VA; Tropé CG; Davidson B
Virchows Arch; 2012 May; 460(5):505-13. PubMed ID: 22476403
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
